| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse. | J Clin Oncol | 2001 | 2.71 |
| 2 | Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin). | Leukemia | 2002 | 1.14 |
| 3 | Impact of age and gender on the pharmacokinetics of gemtuzumab ozogamicin. | Pharmacotherapy | 2001 | 0.76 |